Patent Results
[3.2.0] Heterocyclic Compounds And Methods Of Using The Same
- Published: Jun 9, 2009
- Filed: Oct 1, 2007
- Earliest Priority: Apr 30 2004
- Family: 18
- Cited Works: 100
- Cited by: 26
- Cites: 69
- Additional Info: Cited Works Full text Published
- Owner: Triphase Research And Development I Corp, Nereus Pharmaceuticals Inc
- Applicant: Nereus Pharmaceuticals Inc
Methods Of Using [3.2.0] Heterocyclic Compounds And Analogs Thereof
- Published: Aug 25, 2009
- Filed: Jun 15, 2006
- Earliest Priority: Apr 30 2004
- Family: 2
- Cited Works: 101
- Cited by: 25
- Cites: 68
- Additional Info: Cited Works Full text Published
- Owner: Triphase Research And Development I Corp, Nereus Pharmaceuticals Inc
- Applicant: Nereus Pharmaceuticals Inc
Proteasome Inhibiting Beta Lactam Compounds
- Published: Oct 4, 2007
- Filed: Sep 8, 2006
- Earliest Priority: Sep 12 2005
- Family: 6
- Cited Works: 2
- Cited by: 0
- Cites: 1
- Additional Info: Cited Works Full text Published
- Applicant: Harvard College, Corey Elias J, Hogan Philip C
Proteasome Inhibiting Beta-lactam Compounds
- Published: Dec 16, 2008
- Filed: Sep 12, 2005
- Earliest Priority: Sep 12 2005
- Family: 6
- Cited Works: 36
- Cited by: 6
- Cites: 17
- Additional Info: Cited Works Full text Published
- Owner: President And Fellows Of Harvard College
- Applicant: Harvard College
[3.2.0] Heterocyclic Compounds And Methods Of Using The Same
- Published: Oct 2, 2007
- Filed: Apr 29, 2005
- Earliest Priority: Apr 30 2004
- Family: 18
- Cited Works: 101
- Cited by: 38
- Cites: 57
- Additional Info: Cited Works Full text Published
- Owner: Triphase Research And Development I Corp, Nereus Pharmaceuticals Inc
- Applicant: Nereus Pharmaceuticals Inc
Cytotoxic Agents And Methods Of Use
- Published: May 13, 2008
- Filed: Mar 11, 2005
- Earliest Priority: Mar 12 2004
- Family: 3
- Cited Works: 6
- Cited by: 28
- Cites: 6
- Additional Info: Cited Works Full text Published
- Owner: Miikana Therapeutics Inc
- Applicant: Miikana Therapeutics Inc
Marine Actinomycete Taxon For Drug And Fermentation Product Discovery
- Published: Dec 5, 2006
- Filed: Nov 16, 2001
- Earliest Priority: Nov 16 2000
- Family: 23
- Cited Works: 73
- Cited by: 41
- Cites: 21
- Sequences: 9
- Additional Info: Cited Works Full text Published Sequence
- Owner: Regents Of The University Of California
- Applicant: Univ California
Use Of Nf-κb Inhibition In Combination Therapy For Cancer
- Published: Apr 20, 2010
- Filed: Sep 27, 2006
- Earliest Priority: Oct 28 1997
- Family: 8
- Cited Works: 82
- Cited by: 0
- Cites: 24
- Additional Info: Cited Works Full text Published
- Applicant: Univ North Carolina
Use Nf-κb Inhibition In Combination Therapy For Cancer
- Published: Apr 20, 2010
- Filed: Nov 2, 2004
- Earliest Priority: Oct 28 1997
- Family: 8
- Cited Works: 82
- Cited by: 0
- Cites: 22
- Additional Info: Cited Works Full text Published
- Applicant: Univ North Carolina
Marine Actinomycete Taxon For Drug And Fermentation Product Discovery
- Published: Feb 1, 2011
- Filed: Aug 20, 2007
- Earliest Priority: Nov 16 2000
- Family: 23
- Cited Works: 99
- Cited by: 19
- Cites: 52
- Sequences: 9
- Additional Info: Cited Works Full text Published Sequence
- Applicant: Univ California
{{::'analysis.preview.CITED_WORKS_ANALYSIS.title' | message}}
{{::'analysis.preview.view.full' | message}}
Add New Note
Sorry, you can't add a note to multiple items. You can add a note to your search as a saved query. Did you want to save this search and add a note to it?